FindTrial
Sign In

To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational Study

Evaluation of Efficacy of Sugammadex for Reversal of Neuromuscular Blockade in Patients Undergoing Major Upper Abdominal Surgery: An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055172
Enrollment
50
Registered
2023-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Sugammadex: Dose - 2 mg/kg Frequency - Once Route - Intravenous

Sponsors

Dr. Ram Manohar Lohia Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 Patients posted for major upper abdominal surgery

Exclusion criteria

Exclusion criteria: Refusal to consent ASA 3, 4 and Emergency cases Patients with preoperative respiratory involvement BMI >30

Design outcomes

Primary

MeasureTime frame
To determine the time from administration of Sugammadex till extubation on the basis of Train of Four ratio 0.9Timepoint: After administration of Reversal agent—

Secondary

MeasureTime frame
To detremine the risk of post operative residual paralysis using diaphragm ultrasoundTimepoint: Preoperative baseline 10 minutes after extubation 30 minutes after extubation—

Countries

India

Contacts

Public ContactDr Hiba Iqbal Ali

Dr. Ram Manohar Lohia Institute of Medical Sciences

drshilpi1980@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026